Granulosa Cell Tumor of the Ovary

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors [Phase 2]

  Phase 2 clinical trial update evaluating darolutamide with leuprolide acetate and exemestane in recurrent granulosa cell tumor of the ovary.

• CLINICAL_TRIALS trial_result · 2024-05-08
  Clinical Trial Update: TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas [Phase 1, Phase 2]

  This clinical trial update reports the completion and posted results of a Phase 1/2 study evaluating TRC102 in combination with Temozolomide…

• CLINICAL_TRIALS withdrawal · 2018-03-05
  Clinical Trial Update: Orteronel (TAK-700) in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors. The Greko II Study. [Phase 2]

  Phase 2 trial of Orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors was terminated. No efficacy resu…

• CLINICAL_TRIALS trial_result · 2015-01-21
  Clinical Trial Update: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary [Phase 2]

  A phase 2 trial evaluated ketoconazole as a CYP17 inhibitor in locally advanced or disseminated granulosa cell tumor of the ovary; the study…